Drug comparisons
Exenatide vs Linagliptin
Exenatide vs Linagliptin: GLP-1 agonist vs DPP-4 inhibitor for type 2 diabetes. Differences in injection vs pill, efficacy, weight, and GI side effects.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when selecting incretin therapy for type 2 diabetes, balancing injectable GLP-1 potency against oral DPP-4 convenience.
Bottom line
Exenatide often provides greater glycemic and weight benefits than Linagliptin, which is easier to take and better tolerated.
All medication comparisons